Gallo M - Search Results

1

Nutritional status and follicular-derived thyroid cancer: An update.

Barrea L, Gallo M, Ruggeri RM, Giacinto PD, Sesti F, Prinzi N, Adinolfi V, Barucca V, Renzelli V, Muscogiuri G, Colao A, Baldelli R; E.O.L.O. Group. Barrea L, et al. Among authors: gallo m. Crit Rev Food Sci Nutr. 2021;61(1):25-59. doi: 10.1080/10408398.2020.1714542. Epub 2020 Jan 30. Crit Rev Food Sci Nutr. 2021. PMID: 31997660 Review.

2

The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

Davi MV, Pia A, Guarnotta V, Pizza G, Colao A, Faggiano A; NIKE Group. Davi MV, et al. J Endocrinol Invest. 2017 Jan;40(1):9-20. doi: 10.1007/s40618-016-0536-3. Epub 2016 Sep 13. J Endocrinol Invest. 2017. PMID: 27624297 Review.

3

Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.

Gallo M, Malandrino P, Fanciulli G, Rota F, Faggiano A, Colao A; NIKE Group. Gallo M, et al. J Cancer Res Clin Oncol. 2017 Jul;143(7):1209-1224. doi: 10.1007/s00432-017-2407-5. Epub 2017 Apr 12. J Cancer Res Clin Oncol. 2017. PMID: 28405826 Free article. Review.

4

Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes.

Gallo M, Muscogiuri G, Felicetti F, Faggiano A, Trimarchi F, Arvat E, Vigneri R, Colao A. Gallo M, et al. Metabolism. 2018 Jan;78:141-154. doi: 10.1016/j.metabol.2017.09.013. Epub 2017 Oct 7. Metabolism. 2018. PMID: 28993227 Review.

5

The management of neuroendocrine tumours: A nutritional viewpoint.

Gallo M, Muscogiuri G, Pizza G, Ruggeri RM, Barrea L, Faggiano A, Colao A; NIKE Group. Gallo M, et al. Crit Rev Food Sci Nutr. 2019;59(7):1046-1057. doi: 10.1080/10408398.2017.1390729. Epub 2017 Nov 29. Crit Rev Food Sci Nutr. 2019. PMID: 29020456 Review.

6

Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any?

Gallo M, Ruggeri RM, Muscogiuri G, Pizza G, Faggiano A, Colao A; NIKE Group. Gallo M, et al. Cancer Treat Rev. 2018 Jun;67:1-9. doi: 10.1016/j.ctrv.2018.04.013. Epub 2018 May 2. Cancer Treat Rev. 2018. PMID: 29746922 Review.

7

Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions.

Gallo M, Guarnotta V, De Cicco F, Rubino M, Faggiano A, Colao A; NIKE Group. Gallo M, et al. J Cancer Res Clin Oncol. 2019 Feb;145(2):429-443. doi: 10.1007/s00432-019-02839-w. Epub 2019 Jan 7. J Cancer Res Clin Oncol. 2019. PMID: 30617553 Review.

8

Pancreatic Neuroendocrine Neoplasms: Does Sex Matter?

Muscogiuri G, Barrea L, Feola T, Gallo M, Messina E, Venneri MA, Faggiano A, Colao A; NIKE (Neuroendocrine Tumors, Innovation inKnowledge and Education) Group. Muscogiuri G, et al. Among authors: gallo m. Trends Endocrinol Metab. 2020 Sep;31(9):631-641. doi: 10.1016/j.tem.2020.02.010. Epub 2020 Mar 26. Trends Endocrinol Metab. 2020. PMID: 32223919 Review.

9

Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.

Muscogiuri G, Altieri B, Albertelli M, Dotto A, Modica R, Barrea L, Fanciulli G, Feola T, Baldelli R, Ruggeri RM, Gallo M, Guarnotta V, Malandrino P, Messina E, Venneri MA, Giannetta E, Ferone D, Colao A, Faggiano A; NIKE group. Muscogiuri G, et al. Among authors: gallo m. Endocrine. 2020 Aug;69(2):441-450. doi: 10.1007/s12020-020-02331-3. Epub 2020 May 28. Endocrine. 2020. PMID: 32468269

10

Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues.

Nervo A, Ragni A, Retta F, Gallo M, Piovesan A, Liberini V, Gatti M, Ricardi U, Deandreis D, Arvat E. Nervo A, et al. Among authors: gallo m. J Endocrinol Invest. 2021 Mar;44(3):403-419. doi: 10.1007/s40618-020-01374-7. Epub 2020 Aug 3. J Endocrinol Invest. 2021. PMID: 32743746 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,653 results

Search Page